Volume rose 53% while prices dropped, a sign cheaper access is pulling in patients. Breakdown covers LillyDirect pricing, the $50 Medicare Bridge and Novo's 2027 cuts.
Recap by typeshit. Full story at Medical Daily.
Korea's first homegrown GLP-1 obesity drug, efpeglenatide, comes in about 25% below Wegovy and 40% below Mounjaro for its first four weeks.
MedPage Today
She's screened for diabetes at a BMI of 23 but denied a GLP-1 until 30. She argues insurers should use ethnicity-adjusted thresholds that guidelines already publish.
Pharmacist Paige notes the second round of Medicare drug price negotiation starts January 1, 2027, with the semaglutide family on the list.
New generics and steady prices drove the jump in sales value, with Eli Lilly's tirzepatide leading the market.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
Loading…